ReviewFrontiers in oncology2022
Treatment Advances in EBV Related Lymphoproliferative Diseases.
Kebing Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Kebing Lv et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.